Participants were randomized to either daily minocycline hydrochloride (40 mg); doxycycline, the current standard ... counts ...

In MVOR-2, 60% of patients treated ... and -11.2 in the Emrosi, doxycycline, and placebo arms, respectively. The most common adverse reaction reported in clinical trials was dyspepsia. Emrosi is ...